Chemotherapy and Targeted Therapy

The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery

• Chemotherapy and Targeted Therapy

The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery

Muslim October 8, 2026

In the rapidly evolving landscape of preclinical research, a paradigm shift is underway. For decades, the pathology...

Read More Read more about The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery

The End of an Era: Caribou Biosciences Seeks Strategic Alternatives as Funding Dries Up

• Chemotherapy and Targeted Therapy

The End of an Era: Caribou Biosciences Seeks Strategic Alternatives as Funding Dries Up

Dwi Wanna October 7, 2026

In a stark reminder of the volatility inherent in the biotechnology sector, Caribou Biosciences, a CRISPR-focused pioneer...

Read More Read more about The End of an Era: Caribou Biosciences Seeks Strategic Alternatives as Funding Dries Up

Digital Pathology’s New Frontier: Mining Archival Tissue to Revolutionize Preclinical Research

• Chemotherapy and Targeted Therapy

Digital Pathology’s New Frontier: Mining Archival Tissue to Revolutionize Preclinical Research

Iffa Jayyana October 7, 2026

The landscape of drug discovery is undergoing a profound transformation. What was once a rigid, linear process...

Read More Read more about Digital Pathology’s New Frontier: Mining Archival Tissue to Revolutionize Preclinical Research

Breakthrough in Parkinson’s Research: Cerevance Reports Positive Late-Stage Clinical Trial Results for Solengepras

• Chemotherapy and Targeted Therapy

Breakthrough in Parkinson’s Research: Cerevance Reports Positive Late-Stage Clinical Trial Results for Solengepras

Nana Muazin October 7, 2026

In a significant development for the treatment of neurodegenerative diseases, Boston-based biotechnology firm Cerevance announced on Wednesday...

Read More Read more about Breakthrough in Parkinson’s Research: Cerevance Reports Positive Late-Stage Clinical Trial Results for Solengepras

The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

• Chemotherapy and Targeted Therapy

The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

Siti Muinah October 7, 2026

In the landscape of modern drug discovery, the traditional animal study has long been viewed as a...

Read More Read more about The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

A Vital Infusion: Forbion’s $2.6 Billion Fundraise Signals Hope for European Biotech

• Chemotherapy and Targeted Therapy

A Vital Infusion: Forbion’s $2.6 Billion Fundraise Signals Hope for European Biotech

Nana Wu October 7, 2026

In a move that serves as a high-stakes vote of confidence in the European life sciences sector,...

Read More Read more about A Vital Infusion: Forbion’s $2.6 Billion Fundraise Signals Hope for European Biotech

The Digital Renaissance: Transforming Archived Tissue into the Future of Drug Discovery

• Chemotherapy and Targeted Therapy

The Digital Renaissance: Transforming Archived Tissue into the Future of Drug Discovery

Dwi Wanna October 7, 2026

For decades, the standard lifecycle of a preclinical toxicology slide was linear and finite: a pathologist examined...

Read More Read more about The Digital Renaissance: Transforming Archived Tissue into the Future of Drug Discovery

ArriVent’s Ambitions Stumble: Clinical Setback in Lung Cancer Treatment Wipes Out Half of Market Value

• Chemotherapy and Targeted Therapy

ArriVent’s Ambitions Stumble: Clinical Setback in Lung Cancer Treatment Wipes Out Half of Market Value

Lina Irawan October 7, 2026

By Delilah Alvarado Published October 6, 2026 In a stark reminder of the volatility inherent in biopharmaceutical...

Read More Read more about ArriVent’s Ambitions Stumble: Clinical Setback in Lung Cancer Treatment Wipes Out Half of Market Value

Forbion’s $2.6 Billion Windfall: A Rare Lifeline for Europe’s Cooling Biotech Sector

• Chemotherapy and Targeted Therapy

Forbion’s $2.6 Billion Windfall: A Rare Lifeline for Europe’s Cooling Biotech Sector

Basiran October 7, 2026

By Gwendolyn Wu Published October 6, 2026 In a significant display of resilience for the European life...

Read More Read more about Forbion’s $2.6 Billion Windfall: A Rare Lifeline for Europe’s Cooling Biotech Sector

Digital Pathology’s New Frontier: Mining Archival Tissue to Revolutionize Preclinical Research

• Chemotherapy and Targeted Therapy

Digital Pathology’s New Frontier: Mining Archival Tissue to Revolutionize Preclinical Research

Nana October 7, 2026

The landscape of drug discovery is undergoing a seismic shift. For decades, the path from preclinical animal...

Read More Read more about Digital Pathology’s New Frontier: Mining Archival Tissue to Revolutionize Preclinical Research